[Hopespringpcsg] FW: Fw: ASCO 2015 - Chemotherapy Use in Prostate Cancer: Early or Late?

[Glen Tolhurst]

Hi all:

Interesting article.

Thx.

Glen

 


Subject: Fwd: Fw: ASCO 2015 - Chemotherapy Use in Prostate Cancer: Early or Late?

 

FYI From urotoday.com

 

From: UroToday <editors at urotoday.com>
  
Subject: ASCO 2015 - Chemotherapy Use in Prostate Cancer: Early or Late?

 



 <http://www.urotoday.com/index.php?subid=13579&option=com_acymailing&ctrl=url&urlid=40985&mailid=2713&Itemid=1448> 

 


 <http://www.urotoday.com/index.php?option=com_content&Itemid=101&id=49023&lang=en&view=article> spotlight header


Chemotherapy Use in Prostate Cancer

June 2, 2015

  _____  



Now or Later: Optimal Timing of Docetaxel for Metastatic Prostate Cancer



2 mds talking

Early treatment with docetaxel chemotherapy (Presented by Maha Hussain, MB, ChB)

 


 <http://www.urotoday.com/index.php?Itemid=2516&option=com_content&view=article&catid=1680&id=81081&utm_source=newsletter_2713&utm_medium=email&utm_campaign=asco-2015-chemotherapy-use-in-prostate-cancer-early-or-late-060215&acm=13579_2713> Read More →





Late treatment with docetaxel chemotherapy (Presented by Howard I. Scher, MD)

 


 <http://www.urotoday.com/index.php?Itemid=2516&option=com_content&view=article&catid=1680&id=81082&utm_source=newsletter_2713&utm_medium=email&utm_campaign=asco-2015-chemotherapy-use-in-prostate-cancer-early-or-late-060215&acm=13579_2713> Read More →





Bottom line: Timing of treatment with docetaxel for men with advanced prostate cancer (Presented by Howard I. Scher, MD and Maha Hussain, MB, ChB)

 


 <http://www.urotoday.com/index.php?Itemid=2516&option=com_content&view=article&catid=1680&id=81092&utm_source=newsletter_2713&utm_medium=email&utm_campaign=asco-2015-chemotherapy-use-in-prostate-cancer-early-or-late-060215&acm=13579_2713> Read More →

 


 <http://www.urotoday.com/asco-2015.html?utm_source=newsletter_2713&utm_medium=email&utm_campaign=asco-2015-chemotherapy-use-in-prostate-cancer-early-or-late-060215&acm=13579_2713> View all ASCO 2015 Highlights →


 


 <http://www.urotoday.com/index.php?subid=13579&option=com_acymailing&ctrl=url&urlid=40986&mailid=2713&Itemid=1448> twitter      <http://www.urotoday.com/index.php?subid=13579&option=com_acymailing&ctrl=url&urlid=40987&mailid=2713&Itemid=1448> facebook      <http://www.urotoday.com/index.php?subid=13579&option=com_acymailing&ctrl=url&urlid=40988&mailid=2713&Itemid=1448> linkedin      <http://www.urotoday.com/index.php?subid=13579&option=com_acymailing&ctrl=url&urlid=40989&mailid=2713&Itemid=1448> youtube 


UroToday - 2217 Fifth Street, Berkeley, CA 94710 USA



 <http://www.urotoday.com/index.php?option=com_acymailing&ctrl=archive&task=view&mailid=2713&key=sxCYu5sm&subid=13579-e9ca2e4efd9e5bfe9e07c9e19072ee54&tmpl=component&Itemid=1448&utm_source=newsletter_2713&utm_medium=email&utm_campaign=asco-2015-chemotherapy-use-in-prostate-cancer-early-or-late-060215&acm=13579_2713> View Email in Browser   | 

    <http://www.urotoday.com/index.php?option=com_acymailing&view=user&layout=modify&Itemid=101> Manage Preferences   | 

    <http://www.urotoday.com/index.php?subid=13579&option=com_acymailing&ctrl=user&task=out&mailid=2713&key=e9ca2e4efd9e5bfe9e07c9e19072ee54&Itemid=1448> Unsubscribe   | 

    <http://www.urotoday.com/index.php?option=com_acymailing&ctrl=archive&task=forward&mailid=2713&key=sxCYu5sm&subid=13579-e9ca2e4efd9e5bfe9e07c9e19072ee54&Itemid=1448&utm_source=newsletter_2713&utm_medium=email&utm_campaign=asco-2015-chemotherapy-use-in-prostate-cancer-early-or-late-060215&acm=13579_2713> Forward Email 


You are receiving this email because you have chosen to receive emails from UroToday.  <http://www.urotoday.com/index.php?option=com_comprofiler&Itemid=473&utm_source=newsletter_2713&utm_medium=email&utm_campaign=asco-2015-chemotherapy-use-in-prostate-cancer-early-or-late-060215&acm=13579_2713> Log in to update your email address or view your email preferences. If you have any questions about your account, please log in to contact us securely and we will be happy to assist you.

  <https://449afirp.emltrk.com/449afirp?d=rochab2@yahoo.com>   <http://www.urotoday.com/index.php?option=com_acymailing&ctrl=stats&mailid=2713&subid=13579&Itemid=1448> 

 

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20150603/5e724c66/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: 2mds_060115.jpg
Type: image/jpeg
Size: 30806 bytes
Desc: not available
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20150603/5e724c66/attachment-0001.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: youtube.png
Type: image/png
Size: 2132 bytes
Desc: not available
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20150603/5e724c66/attachment-0004.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: facebook.png
Type: image/png
Size: 805 bytes
Desc: not available
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20150603/5e724c66/attachment-0005.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: twitter.png
Type: image/png
Size: 1896 bytes
Desc: not available
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20150603/5e724c66/attachment-0006.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: linkedin.png
Type: image/png
Size: 852 bytes
Desc: not available
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20150603/5e724c66/attachment-0007.png>